Chimeric antigen receptor T-cells: a review on current status and future directions for relapsed/refractory multiple myeloma.

MLA

Hamadeh, Issam S., et al. “Chimeric Antigen Receptor T-Cells: A Review on Current Status and Future Directions for Relapsed/Refractory Multiple Myeloma.” Frontiers in Oncology, Aug. 2024, pp. 1–15. EBSCOhost, https://doi.org/10.3389/fonc.2024.1455464.

APA

Hamadeh, I. S., Friend, R., Mailankody, S., & Atrash, S. (2024). Chimeric antigen receptor T-cells: a review on current status and future directions for relapsed/refractory multiple myeloma. Frontiers in Oncology, 1–15. https://doi.org/10.3389/fonc.2024.1455464

Chicago

Hamadeh, Issam S., Reed Friend, Sham Mailankody, and Shebli Atrash. 2024. “Chimeric Antigen Receptor T-Cells: A Review on Current Status and Future Directions for Relapsed/Refractory Multiple Myeloma.” Frontiers in Oncology, August, 1–15. doi:10.3389/fonc.2024.1455464.